Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI Worldwide, MilanCPhI Worldwide, Milan
Not Confirmed
Not Confirmed
08-10 October, 2024
Discovery on TargetDiscovery on Target
Not Confirmed
Not Confirmed
30 September-03 October, 2024
Not Confirmed
Not Confirmed
30 September-02 October, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI Worldwide, MilanCPhI Worldwide, Milan
Industry Trade Show
Not Confirmed
08-10 October, 2024
Discovery on TargetDiscovery on Target
Industry Trade Show
Not Confirmed
30 September-03 October, 2024
Industry Trade Show
Not Confirmed
30 September-02 October, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/ice-is-pioneering-sustainability-innovation-in-bile-acid-research-for-neurodegenerative-diseases
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/2024-us-elections-harris-trump-differ-on-abortion-rights-aca-public-health-spends-agree-on-need-to-cut-drug-prices
19 Sep 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/hotspot-therapeutics-appoints-alison-oneill-md-as-chief-medical-officer-302252482.html
12 Sep 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/hotspot-therapeutics-presents-first-in-human-phase-1-clinical-data-on-its-novel-cbl-b-inhibitor-hst-1011-at-esmo-congress-2024-302246957.html
17 Jul 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/hotspot-therapeutics-to-present-initial-first-in-human-phase-1-clinical-data-on-its-novel-cbl-b-inhibitor-hst-1011-at-esmo-congress-2024-302198838.html
20 Jun 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/hotspot-therapeutics-presents-preclinical-data-for-potential-first-in-class-malt1-scaffolding-inhibitor-at-the-4th-aacr-international-meeting-advances-in-malignant-lymphoma-302177499.html
11 Dec 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/hotspot-therapeutics-presents-preclinical-data-for-potential-first-in-class-malt1-scaffolding-inhibitor-at-65th-ash-annual-meeting-302009437.html
02 Nov 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/hotspot-therapeutics-to-introduce-first-in-class-malt1-scaffolding-inhibitor-at-65th-ash-annual-meeting-301975612.html
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?